Intelligent Bio Solutions Partners With IVY Diagnostics, Targets Europe's $3.6 Billion Drug Screening Market

Intelligent Bio Solutions Inc. (Nasdaq: INBS), a medical technology company specializing in intelligent, rapid, and non-invasive testing solutions, has announced a strategic partnership with IVY Diagnostics Srl. This collaboration aims to strengthen Intelligent Bio Solutions' presence in Europe and the Middle East, targeting the growing drug screening market, which is projected to reach $3.6 billion by 2030.



IVY Diagnostics, serving as Intelligent Bio Solutions' primary contact in key European regions, will expand the adoption of the company's Fingerprinting Drug Testing Solution across Europe and the Middle East. The partnership focuses on drug rehabilitation and law enforcement applications, capitalizing on the increasing demand for effective drug screening methods.

The European drug screening market is driven by several key factors, including the growing need for drug rehabilitation programs, the emphasis on workplace safety, and the expanding market for drug testing in safety-critical industries. Intelligent Bio Solutions' innovative, non-invasive drug screening solution addresses these factors by offering rapid results, a non-invasive nature, hygienic and cost-effective methods, ease of use, and compliance with industry standards.

The integration of Intelligent Bio Solutions' drug testing technology into Italian drug rehabilitation programs has a positive impact on the company's revenue streams and market position. By securing a tender with another Italian distributor, IVY Diagnostics, Intelligent Bio Solutions gains access to a new revenue stream and expands its market reach. The positive reception of the technology by rehabilitation centers validates the company's market position and paves the way for further growth opportunities in other European and Middle Eastern markets.

In conclusion, Intelligent Bio Solutions' partnership with IVY Diagnostics positions the company to capitalize on the growing European drug screening market. By addressing key market drivers and offering an innovative, non-invasive drug screening solution, Intelligent Bio Solutions is well-positioned to capture a significant share of the market and drive revenue growth.